发明申请
- 专利标题： Ex vivo modifiable medicament release-substance
- 专利标题（中）： 离体可改性的药物释放物质
-
申请号： US12387311申请日： 2009-04-29
-
公开(公告)号： US20100068256A1公开(公告)日： 2010-03-18
- 发明人: Mahalaxmi Gita Bangera , Edward S. Boyden , Roderick A. Hyde , Muriel Y. Ishikawa , Dennis J. Rivet , Elizabeth A. Sweeney , Lowell L. Wood, JR. , Victoria Y.H. Wood
- 申请人： Mahalaxmi Gita Bangera , Edward S. Boyden , Roderick A. Hyde , Muriel Y. Ishikawa , Dennis J. Rivet , Elizabeth A. Sweeney , Lowell L. Wood, JR. , Victoria Y.H. Wood
- 专利权人： Searete LLC, a limited liability corporation of the State of Delaware
- 当前专利权人： Searete LLC, a limited liability corporation of the State of Delaware
- 主分类号： A61K9/127
- IPC分类号： A61K9/127 ; A61K9/10
摘要：
A described final dosage form includes a substance carrying a medicament in a first medicament-release state having a first bioavailability. The substance is modifiable ex vivo by an exposure to a first stimulus to carry the medicament in a second medicament-release state having a second bioavailability. The substance is modifiable ex vivo by an exposure to a second stimulus to carry the medicament in a third medicament-release state having a third bioavailability. The final dosage form includes another substance carrying another medicament in another first medicament-release state having another first bioavailability. The another substance is modifiable ex vivo by an exposure to another first stimulus to carry the another medicament in another second medicament-release state having another second bioavailability. The another substance is modifiable ex vivo by an exposure to another second stimulus to carry the another medicament in another third medicament-release state having another third bioavailability.
信息查询
